Scotland’s first drug-checking service to open as drug deaths rise by more than 10% According to National Records of Scotland data, the rate of drug use deaths recorded in 2025 is four times the rate observed in 2000 when current records began.…
Children taking GLP-1s can be at risk of nutritional deficiencies, study finds Researchers found that vitamin D deficiency was most frequently observed, and the most common deficiency-related complication was nutritional anaemia.…
GLP-1s: what is behind the variation in efficacy? Researchers are trying to untangle the roles of genetics, access and treatment persistence in the efficacy of GLP-1s. As evidence suggests, weight-loss outcomes are different between patient groups.…
ADHD prescriptions continue to rise as age and sex differences seen in diagnostic rates Figures 'represent people whose lives are getting better' but support for girls with ADHD still 'significantly missed', says charity leader.…
Women with type 2 diabetes more likely than men to develop mental health conditions, study suggests Researchers also found that both women and men who had a combination of type 2 diabetes mellitus and a mental health condition experienced premature mortality compared with other trajectories.…
UK study to look at semaglutide for alcohol addiction and obesity The four-year trial will aim to help “guide future care” for alcohol-related liver disease and obesity in the UK.…
Trust commissions benzodiazepine review following patient death A patient died by suicide after being permanently prescribed diazepam without a required medical review while awaiting a re-titration of her clozapine prescription.…
MHRA approves orforglipron weight-loss pill The Medicines and Healthcare products Regulatory Agency said its approval of orforglipron makes the UK the first country in Europe to authorise the medication.…
UK patients being recruited for ribupatide trials Researchers will assess the efficacy of up to 10mg doses of weight-loss drug ribupatide in patients with or without diabetes over around an 18-month period.…
Incretin-based weight-loss drugs should not be deliberately continued in pregnancy, consensus guidelines state The guidelines have been drawn up by a multidisciplinary group of experts following a systematic scoping review.…